Hiroshige Yoshioka
- Pulmonary and Respiratory Medicine top 0.5%
- Oncology top 0.5%
- Molecular Biology top 10%
- Cancer Research top 5%
- Epidemiology top 5%
- Co-authors
- Nobuyuki YamamotoTakashi SetoKazuhiko NakagawaMakoto NishioTadashi IshidaKatsuyuki KiuraToyoaki HidaNobuyuki Katakami
- Topics
- Lung Cancer Treatments and Mutations (159 papers)Lung Cancer Research Studies (89 papers)Lung Cancer Diagnosis and Treatment (74 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Hiroshige Yoshioka
192 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Pulmonary and Respiratory Medicine 3.6k
- Oncology 3.2k
- Molecular Biology 940
- Cancer Research 589
- Epidemiology 499
Countries citing papers authored by Hiroshige Yoshioka
This map shows the geographic impact of Hiroshige Yoshioka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshige Yoshioka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshige Yoshioka more than expected).
Fields of papers citing papers by Hiroshige Yoshioka
This network shows the impact of papers produced by Hiroshige Yoshioka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshige Yoshioka. The network helps show where Hiroshige Yoshioka may publish in the future.
Co-authorship network of co-authors of Hiroshige Yoshioka
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshige Yoshioka. A scholar is included among the top collaborators of Hiroshige Yoshioka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshige Yoshioka. Hiroshige Yoshioka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 0 | |
| 7 | 3 | |
| 8 | 0 | |
| 9 | 0 | |
| 10 | 7 | |
| 11 | 2 | |
| 12 | 41 | |
| 13 | 5 | |
| 14 | 3 | |
| 15 | 33 | |
| 16 | 1 | |
| 17 | 2 | |
| 18 | 14 | |
| 19 | Carboplatin plus either docetaxel or paclitaxel for Japanese patients with advanced non-small cell lung cancer. | 6 |
| 20 | 4 |
About Hiroshige Yoshioka
Hiroshige Yoshioka is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Geriatrics and Gerontology, having authored 204 papers that have together received 4.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (159 papers), Lung Cancer Research Studies (89 papers) and Lung Cancer Diagnosis and Treatment (74 papers). The work is most often cited by research in Oncology (3.2k citations), Pulmonary and Respiratory Medicine (3.6k citations) and Cancer Research (589 citations). Hiroshige Yoshioka has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Nobuyuki Yamamoto, Takashi Seto, Kazuhiko Nakagawa, Makoto Nishio, Tadashi Ishida, Katsuyuki Kiura, Toyoaki Hida, Nobuyuki Katakami, Tomohide Tamura and Akihiro Nishiyama. Their work appears in journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.